MARATTO

article · Kivu Medical Journal

Chronic Splenomegaly in a young Congolese man revealing Chronic Myeloid Leukemia: a clinical trap for clinicians in resource-limited countries

Abstract

Chronic myeloid leukemia (CML) is one of the most common chronic leukemias. Its diagnosis and treatment pose a significant challenge in sub-Saharan African countries due to the presence of several confusing pathologies and the lack of diagnostic and therapeutic tools, especially when it occurs in young patients. In the present report, a 34-year-old Congolese man was diagnosed with BCR-ABL transcript CML and fortunate enough treated with Imatinib mesylate. Here we describe his clinical picture, his treatment, and his clinical course.

Research topics

  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Myeloid Leukemia Research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.64263/kmj.v3i4.74

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.